LEO Pharma
In 2011 LEO Pharma, a company that had only worked with contract research organizations, took a leap of faith on an academic lab. The result was a 14-step synthesis of ingenol, guided through biweekly calls by Jakob Felding’s team, and a partnership that went on to phorbol, thapsigargin, ouabagenin, calcipotriol and cyclopamine. Few companies have done more to show what patient, ambitious collaboration with academia can achieve.
Ballerup, Denmark
- Papers together
- 13
- Years
- 2013–2024
- Co-authors
- 8
Chemistry we made together
Complex Molecule Synthesis by Electrocatalytic Decarboxylative Cross-CouplingNature 2023
Nineteen-Step Total Synthesis of (+)-PhorbolNature 2016
14-Step Synthesis of (+)-Ingenol from (+)-3-CareneScience 2013
Convergent Total Synthesis of (−)-CyclopamineJ. Am. Chem. Soc. 2023
Overcoming Limitations in Decarboxylative Arylation via Ag–Ni ElectrocatalysisJ. Am. Chem. Soc. 2022
Divergent Synthesis of Pyrone Diterpenes via Radical Cross CouplingJ. Am. Chem. Soc. 2018 All 13 papers with LEO Pharma
-
Nickel-Electrocatalytic Decarboxylative Arylation to Access Quaternary Centers
- Bristol Myers Squibb Daniel Ridge, Jack L. Sloane, Kevin W. Gillman, Martins S. Oderinde, Maximilian D. Palkowitz, Megan A. Emmanuel, Michael D. Mandler
- LEO Pharma Nadia Nasser Petersen, Pablo Martín-Gago, Sebastian Clementson
- Enamine Pavel K. Mykhailiuk
- Biogen Michael C. Nicastri, Philippe N. Bolduc
-
Convergent Total Synthesis of (−)-Cyclopamine
- LEO Pharma Nadia Nasser Petersen, Sebastian Clementson
-
Complex Molecule Synthesis by Electrocatalytic Decarboxylative Cross-Coupling
- Bristol Myers Squibb Martins S. Oderinde, Maximilian D. Palkowitz, Michael D. Mandler, T. G. Murali Dhar
- Pfizer Daniel C. Schmitt, Michael R. Collins
- LEO Pharma Nadia Nasser Petersen, Sebastian Clementson
- Biogen Philippe N. Bolduc, TeYu Chen
- Lilly Daniel C. Schmitt
-
Overcoming Limitations in Decarboxylative Arylation via Ag–Ni Electrocatalysis
- Bristol Myers Squibb Benjamin Vokits, Hao Zhang, Jeremy M. Richter, Martins S. Oderinde, Michael A. Poss, Michael D. Mandler, Peter T. W. Cheng, Scott A. Shaw, T. G. Murali Dhar, Yeheng Zhu
- Pfizer Martin Bravo, Michael R. Collins, Ryan Schioldager
- LEO Pharma Nadia Nasser Petersen, Sebastian Clementson
- Enamine Pavel K. Mykhailiuk
- Biogen Philippe N. Bolduc, TeYu Chen, Vanna D. Blasczak
- Minakem Pierre-Georges Echeverria
-
Convergent Total Synthesis of (+)-Calcipotriol: A scalable, Modular Approach to Vitamin D Analogs
- LEO Pharma Lars Jørgensen, Tine Skak-Nielsen
-
Divergent Synthesis of Pyrone Diterpenes via Radical Cross Coupling
- LEO Pharma Jakob Felding
-
Divergent Synthesis of Thapsigargin Analogs
- LEO Pharma Georg Dünstl, Jakob Felding
-
Chemical Proteomics Identifies SLC25A20 as a Functional Target of the Ingenol Class of Actinic Keratosis Drugs
- LEO Pharma Bjarne Nørremark, Georg Dünstl, Jakob Felding, Lars Jørgensen
-
Scalable Synthesis of (–)-Thapsigargin
- LEO Pharma Jakob Felding
-
Nineteen-Step Total Synthesis of (+)-Phorbol
- LEO Pharma Jakob Felding
-
C–H Oxidation of Ingenanes Enables Potent and Selective Protein Kinase C Isoform Activation
- LEO Pharma Georg Dünstl, Jakob Felding
- Kemxtree Swaminathan R. Natarajan
-
Development of a Concise Synthesis of Ouabagenin and Hydroxylated Corticosteroid Analogues
- LEO Pharma Georg Dünstl, Jakob Felding
-
14-Step Synthesis of (+)-Ingenol from (+)-3-Carene
- LEO Pharma Jakob Felding
No papers match these filters.
Our co-authors at LEO Pharma
Sebastian Clementson · Georg Dünstl · Jakob Felding · Lars Jørgensen · Pablo Martín-Gago · Bjarne Nørremark · Nadia Nasser Petersen · Tine Skak-Nielsen
Some of these papers were shared with 7 other partners: Bristol Myers Squibb, Enamine, Biogen, Pfizer, Eli Lilly and Company, Minakem, Kemxtree.
More partners
Enamine
HitGen Hongene Biotech Hongene Biotech IKA IKA InduPro Therapeutics InduPro Therapeutics
KULR Technology RQx Pharmaceuticals RQx Pharmaceuticals Socrates Biosciences Socrates Biosciences The Medicines Company The Medicines Company Interested in collaborating with the Baran lab?
If your team has a problem that matters, a molecule no one can make, a reaction that will not scale, a reagent that should exist, we would love to hear about it.
Email Philor write to pbaran@scripps.edu